10-Q Filing

LifeMD, Inc. CIK: 948320 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001213900-16-016025`
Period End Date	20160630
Filing Date	20160815
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	immd-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 38 Income Statement 68 Cash Flow Statement 44 Stockholders Equity 13

Balance Sheet 38 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	34.31M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$79.55K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.01M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$235.45K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	34.31M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.01M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$451.07K	USD	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$154.44K	USD	Point-in-time
Inventory, net	`InventoryNet`	$179.25K	USD	Point-in-time
Inventory, net	`InventoryNet`	$61.05K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$448.47K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$865.78K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$167.48K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$421.64K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$100.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$100.00K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$267.48K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$521.64K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,310,375 and 32,010,375 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$320.10K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,310,375 and 32,010,375 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$343.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.78M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.59M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.85M	USD	Point-in-time
Total Immudyne, Inc. Stockholders' Equity	`StockholdersEquity`	$278.23K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' Equity	`StockholdersEquity`	$100.08K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$65.91K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$80.91K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$344.14K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$448.47K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$865.78K	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net sales	`Revenues`	$277.35K	USD	1 Quarter
Net sales	`Revenues`	$2.87M	USD	2 Qtrs
Net sales	`Revenues`	$1.23M	USD	1 Quarter
Net sales	`Revenues`	$565.63K	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$700.98K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$89.50K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$163.72K	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$2.04M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$187.85K	USD	1 Quarter
Gross Profit	`GrossProfit`	$401.91K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$829.36K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$526.27K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$114.77K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$715.51K	USD	2 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$200.16K	USD	2 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$475.06K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$125.36K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$194.67K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$26.31K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$61.82K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$79.49K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$149.26K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$177.90K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$63.93K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$679.90K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$411.25K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$205.02K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-153.63K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-17.17K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-258.73K	USD	2 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-9.34K	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$18.63K	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$2.75K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$5.81K	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$8.16K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-27.96K	USD	2 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-264.54K	USD	2 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-25.33K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-156.38K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-8.60K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-264.54K	USD	2 Qtrs
Net (Loss)	`ProfitLoss`	$-156.38K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-21.03K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-19.36K	USD	2 Qtrs
Net Income (Loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net Income (Loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$43.59K	USD	1 Quarter
Net Income (Loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.52K	USD	2 Qtrs
Net Income (Loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net (Loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-19.36K	USD	2 Qtrs
Net (Loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-21.03K	USD	1 Quarter
Net (Loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-262.02K	USD	2 Qtrs
Net (Loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-199.98K	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$32.34M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$32.17M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$30.65M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$30.20M	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$32.17M	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$30.65M	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$30.20M	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$32.34M	USD	1 Quarter

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net (Loss)	`ProfitLoss`	$-264.54K	USD	2 Qtrs
Net (Loss)	`ProfitLoss`	$-156.38K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-21.03K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-19.36K	USD	2 Qtrs
Depreciation	`Depreciation`	-	USD	2 Qtrs
Depreciation	`Depreciation`	$28.49K	USD	2 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-8.60K	USD	2 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$118.56K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$4.00K	USD	2 Qtrs
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$230.00K	USD	2 Qtrs
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$120.36K	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$296.64K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-19.53K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$118.20K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$254.16K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$39.87K	USD	2 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-76.66K	USD	2 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-56.43K	USD	2 Qtrs
Investment in subsidiary by noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$79.13K	USD	2 Qtrs
Investment in subsidiary by noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	2 Qtrs
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	$130.00K	USD	2 Qtrs
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	-	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$58.71K	USD	2 Qtrs
Purchase of Company stock	`ProceedsFromIssuanceOfCommonStock`	$-10.80K	USD	2 Qtrs
Purchase of Company stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$79.13K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.49K	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.05K	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.47K	USD	2 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$79.55K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$235.45K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$79.55K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$235.45K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$5.81K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaid`	$18.63K	USD	2 Qtrs

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$344.14K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Amortization of stock options	`AdjustmentsOfAdditionPaidInCapitalAmortizationOfStockOptions`	$77.73K	USD	2 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$230.00K	USD	2 Qtrs
Reduction in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	-	USD	2 Qtrs
Issuance of stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$40.83K	USD	2 Qtrs
Investment in subsidiary by noncontrolling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$79.13K	USD	2 Qtrs
Net (loss)	`ProfitLoss`	$-264.54K	USD	2 Qtrs
Net (loss)	`ProfitLoss`	$-156.38K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-21.03K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-19.36K	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$344.14K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.